DEGARELIX ROLE AND PLACE IN THE COMBINED TREATMENT OF PATIENTS WITH PROSTATE CANCER IN COMBINATION WITH CONCURRENT RADIOTHERAPY

Application Degarelix ADT patients who underwent combined radiotherapy, already on the first results showed the high efficiency and low toxicity. For patients with localized prostate cancer with intermediate factors and a poor prognosis, as well as for patients with locally advanced disease, we reco...

Full description

Bibliographic Details

Published in:	Сибирский онкологический журнал
Main Authors:	A. Y. Pavlov, R. A. Gafanov, S. V. Fastovets, A. D. Tsybulsky, T. K. Isaev
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Subjects:	prostate cancer hormone therapy medical castration an antagonist of gonadotropin-releasing hormone
Online Access:	https://www.siboncoj.ru/jour/article/view/254